News
On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the plate with a major plan to grow its U.S. footprint. | As concerns around ...
9don MSN
Some industries have escaped these moves by the administration, at least for now. One of them is the pharmaceutical industry.
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...
Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback